Abhishek Karande of SBICAP Securities told CNBC-TV18, "I am quite bullish on Maruti Suzuki India. I see price is traveling to at least Rs 2,200. So any pullback of 3-4 percent you should buy it out. The yearly charts have breached on the Maruti as well, so that stock I am quite bullish."
He further added, "In pharmaceutical space, I am bullish on Ranbaxy Laboratories. I feel that stock will travel beyond Rs 520 from current market levels."
Disclosure: He may have recommended the above stock to his clients as a part of their holdings.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!